Japan Price Cuts For Epkinly and Lunsumio Following CEA

Wegovy, Leqembi And Others In Spotlight

 
• By Lisa Takagi
  
Japan's CAE scheme
Japan cuts prices, looks at products under cost effectiveness scheme (Shutterstock/AI-generated)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Government Payers

More from Japan